
Devika Syamnath
None at Reuters
Articles
-
1 week ago |
today.westlaw.com | Sriparna Roy |Devika Syamnath
(Reuters) -Eli Lilly said on Thursday it would appeal against a UK agency's recommendation to not reimburse the cost of Alzheimer's drug Kisunla, blocking access for patients seeking treatment under the country's state-run health service.
-
1 week ago |
today.westlaw.com | Bhanvi Satija |Sriparna Roy |Shailesh Kuber |Devika Syamnath
(Reuters) -Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website starting early August, the U.S. drugmaker said on Monday. With the addition of the 12.5 milligrams and 15 mg doses,...
-
4 weeks ago |
cp24.com | Arasu Kannagi Basil |Devika Syamnath
Royal Bank of Canada reported a jump in second-quarter profit on Thursday, as the country's biggest bank benefited from the acquisition of HSBC's domestic business and strength in its wealth management business. The $13.5 billion acquisition of HSBC Canada, the largest deal in RBC's history, has tightened the bank's grip at home and positioned it for more growth and scale. The inclusion of HSBC's Canadian operations boosted RBC's net income by $258 million.
-
1 month ago |
today.westlaw.com | Aatreyee Dasgupta |Devika Syamnath
(Reuters) -Union members at General Dynamics' Electric Boat submarine-making unit have voted to ratify a new contract, the United Auto Workers said on Wednesday. The union, representing over 2,400 marine drafters at Electric Boat, said 85% voted in...
-
1 month ago |
today.westlaw.com | Sriparna Roy |Yadarisa Shabong |Devika Syamnath
(Reuters) -Spero Therapeutics and partner GSK are stopping a late-stage trial of an experimental oral drug for complicated urinary tract infections early as the study met its main goal, the companies said on Wednesday. Shares of Spero more than...
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →